Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-γ production

This publication has 31 references indexed in Scilit:

• CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
  Nature, 2002
• The immunology of susceptibility and resistance to Leishmania major in mice
  Nature Reviews Immunology, 2002
• Expression of Inducible Nitric Oxide Synthase in Skin Lesions of Patients with American Cutaneous Leishmaniasis
  Infection and Immunity, 2002
• High Intralesional Interleukin‐10 Messenger RNA Expression in Localized Cutaneous Leishmaniasis Is Associated with Unresponsiveness to Treatment
  The Journal of Infectious Diseases, 2001
• Comparison of the Immune Profile of Nonhealing Cutaneous Leishmaniasis Patients with Those with Active Lesions and Those Who Have Recovered from Infection
  Infection and Immunity, 2000
• The IgG isotypes of specific antibodies in patients with American cutaneous leishmaniasis; relationship to the cell‐mediated immune response
  Parasite Immunology, 1996
• Tumor necrosis factor-α in human American tegumentary leishmaniasis
  Memórias do Instituto Oswaldo Cruz, 1996
• Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major.
  The Journal of Experimental Medicine, 1994
• Cytokine patterns in the pathogenesis of human leishmaniasis.
  Journal of Clinical Investigation, 1993
• Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
  The Journal of Experimental Medicine, 1990